1. Home
  2. BVS vs CCAP Comparison

BVS vs CCAP Comparison

Compare BVS & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$9.89

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Logo Crescent Capital BDC Inc.

CCAP

Crescent Capital BDC Inc.

HOLD

Current Price

$13.05

Market Cap

456.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
CCAP
Founded
2011
2015
Country
United States
United States
Employees
N/A
250
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
617.1M
456.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
BVS
CCAP
Price
$9.89
$13.05
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$14.00
$15.93
AVG Volume (30 Days)
410.7K
193.5K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
13.27%
EPS Growth
163.46
N/A
EPS
0.33
N/A
Revenue
$568,087,000.00
N/A
Revenue This Year
$7.52
N/A
Revenue Next Year
$7.06
N/A
P/E Ratio
$28.56
$14.18
Revenue Growth
N/A
N/A
52 Week Low
$5.81
$11.80
52 Week High
$9.53
$16.50

Technical Indicators

Market Signals
Indicator
BVS
CCAP
Relative Strength Index (RSI) 69.02 56.44
Support Level $8.43 $12.56
Resistance Level N/A $13.48
Average True Range (ATR) 0.35 0.33
MACD 0.05 0.08
Stochastic Oscillator 100.00 97.33

Price Performance

Historical Comparison
BVS
CCAP

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About CCAP Crescent Capital BDC Inc.

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Share on Social Networks: